Mouse mammary tumor lines expressing estrogen and progesterone receptors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 26, 2004
Grant Date -
N/A
app pub date -
Jul 11, 2000
filing date -
Jul 11, 2000
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention relates to the generation of mouse mammary adenocarcinoma cell lines which express estrogen and progesterone receptors as a tool to study the effect of hormones, pharmacological compounds and environmental agents. The invention also relates methods in vitro and in vivo for testing hormones or another related molecules by cell proliferation or tumor proliferation.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully